Orchid Pharma Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 68,916 shares,. Its Average Traded Price (ATP) is ₹987.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1003.05.
Orchid Pharma has an upper circuit limit of ₹1203.65 and a lower circuit limit of ₹802.45. The total value traded stands at ₹6.80 CR, and the delivery percentage for the day is 61.07%.
The stock is currently traded with a market lot size of 1. Orchid Pharma also offers a dividend yield of 0%.
Orchid Pharma Share Price Chart
Orchid Pharma Share Key Metrics
Volume
68916.00
Market Cap
5087.38 CR
LTQ@LTP
5@1003.05
ATP
987.16
Var Margin
100 %
Circuit Range
802.45-1203.65
Delivery %
61.07 %
Value
6.80 CR
ASM/GSM
No
Market Lot
1
Orchid Pharma Resistance and Support
Pivot 995.53
Resistance
First Resistance
1017.51
Second Resistance
1031.98
Third Resistance
1053.96
Support
First Support
981.06
Second Support
959.08
Third Support
944.61
Orchid Pharma Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Orchid Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2026-08-01 | Allotment of Equity Shares |
Orchid Pharma News
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Change in Management
Orchid Pharma's board approved the appointment of Mr. Arjun Dhanuka as Whole-Time Director, effective September 3, 2026, for a five-year term. He has over a decade of experience in the pharmaceutical sector.
Sep 03 2026 20:29:30
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting
Orchid Pharma's board appointed Mr. Arjun Dhanuka as Whole-Time Director for five years, effective September 3, 2026. He was previously a Non-Executive Director and will serve until September 2, 2031. The board also approved the notice for the 33rd AGM on September 29, 2026.
Sep 03 2026 20:16:28
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Orchid Pharma announced the upload of the audio recording for its Analysts/Investors Earnings Call, which took place on August 21, 2026. The call focused on the unaudited Q1 FY27 financial results, providing investors access to the detailed discussion.
Aug 21 2026 20:18:47
Orchid Pharma Management
| Name | Position |
|---|---|
| Ram Gopal Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
Orchid Pharma Similar Stocks
Sanofi India Ltd.
3079.20
0.00 (0.00%)
Kovai Medical Center & Hospital Ltd.
6203.50
0.00 (0.00%)
Senores Pharmaceuticals Ltd.
1467.30
0.00 (0.00%)
Innova Captab Ltd.
1147.20
0.00 (0.00%)
Morepen Laboratories Ltd.
115.78
0.00 (0.00%)
IOL Chemicals And Pharmaceuticals Ltd.
194.31
0.00 (0.00%)
FDC Ltd.
341.45
0.00 (0.00%)
Gujarat Themis Biosyn Ltd.
422.65
0.00 (0.00%)
Artemis Medicare Services Ltd.
344.90
0.00 (0.00%)
Supriya Lifescience Ltd.
901.75
0.00 (0.00%)
Orchid Pharma FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ORCHPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in ORCHPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade